FDMT vs XPO · rev $6.8M vs P/E 69, rev $2.35B
4D Molecular Therapeutics Inc (FDMT) versus XPO Logistics Inc (XPO) — a side-by-side from cached financials, not a winner call.
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
XPO Logistics Inc (XPO) is a trucking company listed on NYSE.
Latest reported FDMT revenue for 2026-06-30 was $6.8M. Net income was -$141.7M. FDMT currently screens at market cap $518.1M.
Latest reported XPO revenue for 2026-06-30 was $2.35B. Net income was $162.0M. Revenue was up 12.4% from 2026-03-31 to 2026-06-30. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
FDMT currently screens at market cap $518.1M. XPO currently screens at market cap $23.69B and trailing P/E 69.3.
Not investment advice. Open the FDMT and XPO stock pages for the full models.
Not investment advice.